Abstract 397: Hydrogen Inhalation in Combination With Hypothermic Temperature Control Improves Survival After Out-of-Hospital Cardiac Arrest
Abstract only Background: In a randomized trial, we demonstrated that hydrogen (H 2 ) inhalation improves the outcomes after cardiac arrest (CA). All patients underwent target temperature management (TTM) in this trial, but the selection of a target temperature between 32 and 36 °C varied per instit...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 148; no. Suppl_1 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
07.11.2023
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only
Background:
In a randomized trial, we demonstrated that hydrogen (H
2
) inhalation improves the outcomes after cardiac arrest (CA). All patients underwent target temperature management (TTM) in this trial, but the selection of a target temperature between 32 and 36 °C varied per institutional protocol. This study aimed to investigate the interaction of H
2
and hypothermic TTM on survival after CA.
Methods:
This post-hoc analysis of a randomized controlled trial (HYBRID II Trial; jRCTs031180352) included comatose patients after cardiogenic out-of-hospital CA (OHCA). They received either 2% H
2
mixed oxygen (H
2
group) or oxygen alone (control group) for 18 hours under hypothermic TTM (<35°C) or normothermic TTM (35-36°C). A target temperature was reached quickly, maintained for 24 hours, and rewarmed over 48 hours. The survival rate was compared between the H
2
and control groups under hypothermic or normothermic TTM.
Results:
The analysis included 72 patients with outcome data (39 and 33 patients in the H
2
and control group, respectively). Hypothermic TTM was implemented in 25 (64%) and 24 (73%) patients in the H
2
and control group, respectively (P=0.46). Under hypothermic TTM, the 90-day survival rate was 88% (22/25) and 46% (11/24) in the H
2
and control group, respectively (P=0.01). In contrast, under normothermic TTM, 78% (7/9) and 79% (11/14) of patients survived 90 days in the H
2
and control group, respectively (P=0.93). The interaction between H
2
and hypothermic TTM was independently associated with 90-day survival in a multivariable logistic regression model (adjusted odds ratio 7.79 [95%CI: 1.46-41.6]), however, it was marginally significant in the Cox proportional hazards model (adjusted hazard ratio 0.33 [95%CI: 0.10-1.17]) after adjusting for confounding factors including age, sex, witness status, bystander CPR implementation, shockable rhythm, CA duration, and time from the return of spontaneous circulation to gas inhalation, respectively.
Conclusions:
H
2
in combination with hypothermic TTM improved 90-day survival after OHCA but not under normothermic TTM. |
---|---|
ISSN: | 0009-7322 1524-4539 |
DOI: | 10.1161/circ.148.suppl_1.397 |